Development of a ZHER3‐Affibody‐Targeted Nano‐Vector for Gene Delivery to HER3‐Overexpressed Breast Cancer Cells

Despite the initial successes of gene delivery applications, they faced on several intrinsic drawbacks including toxicity and immunogenicity. Therefore, alternative gene‐delivery systems derived from recombinant peptides have emerged and is rapidly developing. Human epidermal growth factor receptor‐...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Macromolecular bioscience 2019-11, Vol.19 (11), p.e1900159-n/a
Hauptverfasser:	Nazari, Mahboobeh, Zamani Koukhaloo, Saeideh, Mousavi, Samira, Minai‐Tehrani, Arash, Emamzadeh, Rahman, Cheraghi, Roya
Format:	Artikel
Sprache:	eng
Schlagworte:	affibody Arginine biomimetic peptide Biomimetics Biopolymers Breast cancer Deoxyribonucleic acid Diagnostic software Diagnostic systems DNA Epidermal growth factor ErbB-2 protein gene delivery Gene transfer Genes Growth factors human epidermal growth factor receptor‐3 Immunogenicity Nanoparticles nano‐vector Peptides RALA Receptors Toxicity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!